1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Pulmonary Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Pulmonary Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • August 2018
  • 346 pages
  • ID: 4743092
  • Format: PDF
  • By Transparency Market Research

Summary

Table of Contents

Global Pulmonary Drug Delivery Devices Market: Overview
The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non-pulmonary diseases.Inhalation therapy is the best option to treat to treat lung diseases such as asthma and cystic fibrosis.

The global pulmonary drug delivery devices market is expanding at a significant pace due to factors such as increase in incidence of lung diseases and rise in digitalization of inhaler devices, which offers convenience to patients.

The global pulmonary drug delivery devices market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on product, application, distribution channel, and region.

A detailed qualitative analysis of drivers, restraints, and opportunities has been provided in the market overview section.Additionally, the section comprises competitive matrix and company profiles to understand the competitive landscape in the market.

This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pulmonary drug delivery devices market.

Global Pulmonary Drug Delivery Devices Market: Key Segments
In terms of product, the global pulmonary drug delivery devices market has been segmented into dry powder inhalers, metered dose inhalers, and nebulizers.The dry powder inhalers segment has been further sub-segmented into single dose inhalers, and multi-dose inhalers.

The metered dose inhalers segment has been further split into total manually-actuated pressurized inhaler and breath-actuated pressurized inhaler.The nebulizers segment has been further sub-segmented into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers.

The product segment has been analyzed based on different type of devices uses to treat different pulmonary diseases in various regions.The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of application, the global pulmonary drug delivery devices market has been segregated into asthma, COPD, cystic fibrosis, and others. In term of end-user, the global pulmonary drug delivery devices market has been classified into retail pharmacies, hospital pharmacies, and e-commerce. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year.

Global Pulmonary Drug Delivery Devices Market: Regional Outlook
The global pulmonary drug delivery devices market has been segmented into five major regions and key countries/sub-regions in the respective region are: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of MEA). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year. The research study also provides the competitive scenario in these regions.

Companies Mentioned in Report
The report also profiles major players in the market in terms of various attributes such as company overview, financial overview, devices portfolios, business strategies, and recent developments. Major companies profiled in the global pulmonary drug delivery devices market include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Koninklijke Philips N.V., 3M Healthcare, Omron Corporation, F. Hoffmann-La Roche Ltd., Novartis AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., MannKind Corporation, Mylan N.V., Sunovion Pharmaceuticals, Inc., PARI GmbH, and Nypro Healthcare Inc. (Jabil Circuit Inc.) The global pulmonary drug delivery devices market has been segmented as follows:

Global Pulmonary Drug Delivery Devices Market, by Product
Dry Powder Inhalers
Single Dose Inhalers
Multi-dose Inhalers
Metered Dose Inhalers
Manually-actuated Pressurized Inhaler
Breath-actuated Pressurized Inhaler
Nebulizers
Jet Nebulizers
Ultrasonic Wave Nebulizers
Vibrating Mesh Nebulizers

Global Pulmonary Drug Delivery Devices Market, by Application
Asthma
COPD
Cystic Fibrosis
Others

Global Pulmonary Drug Delivery Devices Market, by Distribution Channel
Retail Pharmacies
Hospital Pharmacies
E-commerce

Global Pulmonary Drug Delivery Devices Market, by Region
North America
S.
Canada
Europe
Germany
K.
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off

($5795)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Drug Delivery: Inhalation Devices

Drug Delivery: Inhalation Devices

  • $ 4750
  • October 2019

OverviewIn 2018, combined sales of inhaled asthma and COPD devices in the countries covered by this analysis totaled approximately $10.4bn. Over the forecast period covered by this analysis, total sales ...

Asia Pacific Drug Delivery Systems Market to 2027 - Regional Analysis and Forecasts by Route of Administration; Distribution Channel; and Application, and Country

Asia Pacific Drug Delivery Systems Market to 2027 - Regional Analysis and Forecasts by Route of Administration; Distribution Channel; and Application, and Country

  • $ 3000
  • October 2019

The Asia Pacific drug delivery systems market is expected to reach US$ 441,337.0 Mn in 2027 from US$ 212,012.7 Mn in 2018. The market is estimated to grow with a CAGR of 8.6% from 2019-2027.The growth ...

Dry Powder Inhaler Devices Device Pipeline Study- Analysis of Devices under Development, Companies, Developments and Outlook

Dry Powder Inhaler Devices Device Pipeline Study- Analysis of Devices under Development, Companies, Developments and Outlook

  • $ 1799
  • July 2019

Global Dry Powder Inhaler Devices market is one of the largely focused segments of medical devices worldwide. The global Dry Powder Inhaler Devices industry is estimated to be around $0.7 billion in 2019 ...

Global Autoinjectors Industry $ 4950 October 2019


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on